Riskpilot← Back to searchSign inGet full accessNovavox Oy Ab
OYActiveY-tunnus 2755836-2Metsänneidonkuja 10Wholesale of pharmaceutical and medical goods · NACE 4646Est. 2016— employees
Revenue 2024
EUR 85K
+3% vs 2023
EBITDA margin
-28.2%
-3% vs 2023
Equity ratio
-254.8%
Financial strength
Net profit 2024
EUR -25K
-2% vs 2023
| Revenue | EUR 85K | +3% |
| EBITDA | EUR -24K | -3% |
| Net profit | EUR -25K | -2% |
| Total assets | EUR 45K | -5% |
| Equity | EUR -114K | -368% |
| Employees | — | — |
Legal name
Novavox Oy Ab
Y-tunnus number
2755836-2
Legal form
Osakeyhtiö
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
6. huhtikuuta 2016
Share capital
EUR 3 000
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Kuulokojeiden, kuulonapuvälineiden ja paristojen myynti ja maahantuonti. Kuulokojeiden sovitus, kuulonkuntoutuspalvelut, kuulon huolto ja muu alaan liittyvä laitemyynti ja –asennus. Kuuloalaa kattava neuvonta, konsultointi ja koulutus. Yhtiö voi myös käydä arvopaperikauppaa ja omistaa osakkeita.
Address
Metsänneidonkuja 10
Phone
+358505260381
Email
johan.wikstrom@novavox.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 64 | 50 | 80 | 83 | 85 |
| Staff expenses | −2 | −2 | −1 | −4 | −4 |
| EBITDA | −17 | −16 | −22 | −23 | −24 |
| Depreciation & amort. | −1 | −1 | −1 | −1 | −0 |
| EBIT | −18 | −17 | −22 | −24 | −24 |
| Net financials | −0 | — | −1 | −0 | −0 |
| Profit before tax | −18 | −17 | −23 | −24 | −25 |
| Tax | −0 | −0 | 0 | −0 | −0 |
| Net profit | −18 | −17 | −23 | −24 | −25 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 103 | 86 | 63 | 47 | 45 |
| Equity | −24 | −41 | 56 | −24 | −114 |
| Long-term debt | 121 | 121 | — | 121 | 121 |
| Short-term debt | 6 | 6 | 6 | 15 | 37 |
| Total debt | 127 | 127 | 6 | 136 | 158 |
EBITDA margin
-28.2%
This company
15.8%
Market median
-278% vs market
20202024
Equity ratio
-254.8%
This company
38.2%
Market median
-767% vs market
20202024
Return on equity
-2473500.0%
This company
18.4%
Market median
-13443035% vs market
20202024
Net profit margin
-29.1%
This company
8.1%
Market median
-459% vs market
20202024
Asset turnover
1.91×
This company
1.12×
Market median
+71% vs market
20202024
Debt / equity
1.39×
This company
0.62×
Market median
-124% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JA Chief Executive Officer | Chief Executive Officer | 2016 |
PJ Deputy Member | Deputy Member | 2016 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Novavox Oy Ab also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Andreas Wikström | Chief Executive Officer | 0 companies |
| Patrik Johan Wikström | Deputy Member | 0 companies |